购物车
- 全部删除
- 您的购物车当前为空
RI-AG03是口服活性且能够穿过血脑屏障的Tau聚集肽抑制剂。RI-AG03能够在体内外模型中阻止Tau聚集,并改善相关神经退行性和行为表型,适用于阿尔茨海默症等Tau蛋白病的研究。
RI-AG03是口服活性且能够穿过血脑屏障的Tau聚集肽抑制剂。RI-AG03能够在体内外模型中阻止Tau聚集,并改善相关神经退行性和行为表型,适用于阿尔茨海默症等Tau蛋白病的研究。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 期货 | |
50 mg | 询价 | 期货 |
产品描述 | RI-AG03 is an orally active peptide inhibitor capable of crossing the blood-brain barrier, targeting Tau aggregation. It effectively inhibits Tau aggregation in both in vivo and in vitro models, improving associated neurodegenerative and behavioral phenotypes. RI-AG03 is applicable in research on Tauopathies such as Alzheimer's disease. |
分子量 | 2477.93 |
分子式 | C104H189N49O22 |
存储 | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
评论内容